Table 2 Tumor response and overall survival of BCLC-C advanced HCC patients.
Tumor response rate (per target lesion) at 1st follow-up within 3 months | |
|---|---|
Complete Response | 27/86 (31.4%) |
Partial Response | 23/86 (26.7%) |
Stable Disease | 26/86 (30.2%) |
Progressivea Disease | 10/86 (11.6%) |
Objective Response | 58.1% |
Disease Control Rate | 88.4% |
OS/person (per patient) | |
Median OS (months) | 15.9 ± 8.7 |
1-year OS rate | 38/64 (59.3%) |
2-year OS rate | 14/64 (21.8%) |
